Codes / ICD10CM / L12.3

L12.3 Acquired epidermolysis bullosa

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Acquired epidermolysis bullosa

Summary

Acquired epidermolysis bullosa is a rare autoimmune blistering disorder that primarily affects the skin and mucous membranes. The condition results from the immune system mistakenly attacking proteins in the skin, leading to fluid-filled blisters and inflammation. It can vary in severity, with some cases causing localized symptoms and others affecting multiple areas of the body.

Causes

The exact cause of acquired epidermolysis bullosa is not fully understood, but it is believed to involve an autoimmune response where the body produces antibodies that target specific proteins in the skin or mucous membranes. This immune reaction disrupts the adhesion between skin layers, resulting in blister formation.

Risk Factors

  • Age: Most commonly diagnosed in older adults, though it can occur at any age.
  • Autoimmune conditions: Individuals with other autoimmune diseases may have an increased risk.
  • Certain medications: Some drugs have been associated with triggering the condition in susceptible individuals.

Symptoms

  • Blisters on the skin or mucous membranes (e.g., mouth, eyes, genitals).
  • Itching, redness, or irritation in affected areas.
  • Pain or discomfort, particularly when blisters rupture.
  • In severe cases, widespread blistering may occur.

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, skin biopsy, and immunofluorescence testing to detect specific antibodies. Blood tests may also be used to identify circulating antibodies associated with the condition.

Treatment Options

Treatment focuses on managing symptoms and suppressing the immune response. Options may include topical or systemic corticosteroids, immunosuppressive medications, and wound care to prevent infection and promote healing.

Prognosis and Follow-Up

The prognosis varies depending on the severity and extent of the condition. With appropriate treatment, many individuals experience symptom relief, but the condition may require ongoing management. Regular follow-up with a healthcare provider is important to monitor for complications and adjust treatment as needed.

Complications

Potential complications include secondary infections, scarring, and in severe cases, vision impairment or difficulty swallowing if mucous membranes are affected.

Lifestyle & Prevention

Avoiding trauma to the skin, using gentle skincare products, and protecting against friction or pressure can help reduce blister formation. Maintaining good hygiene and promptly treating any skin injuries may also minimize complications.

When to Seek Professional Help

Seek medical attention if you develop unexplained blisters, persistent skin irritation, or symptoms that worsen or spread. Early diagnosis and treatment can help manage the condition and prevent complications.

Tips for Medical Coders

When coding for acquired epidermolysis bullosa (L12.3), ensure documentation supports the diagnosis, including clinical findings, biopsy results, and any associated autoimmune conditions. Verify that the code aligns with the specific subtype and any documented complications.

Book a walkthrough

L12.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.